More FDA protectionism that works against patient interests. Action Alert! The FDA has announced its intent to issue a proposed rule this coming August that would extend the agency’s power over laboratory developed tests (LDTs). This is a critical threat, as LDTs are crucial tools used in personalized medicine because labs can create custom diagnostic tests for all sorts of health conditions. Read more.